ArticleJournal of pain research2025
Effect of Succinylcholine on Postoperative Sore Throat in Hysteroscopic Surgery with Laryngeal Mask Airway (LMA): A Randomized Trial.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the impact of succinylcholine on the incidence of postoperative sore throat (POST) in patients undergoing hysteroscopy under laryngeal mask airway (LMA)-assisted general anesthesia. Design: A prospective, randomized, double-blind clinical study. Setting: A tertiary-level hospital. Patients: Out of 154 screened patients, 144 completed the study. Participants were those undergoing daytime hysteroscopic surgery under LMA-assisted general anesthesia. Interventions: Patients were randomly assigned to receive either succinylcholine group (Group S) or 0.9% saline (Group N) during anesthesia induction. Groups S received succinylcholine at 1 mg/kg, while Group N received an equal volume of 0.9% saline. Primary and Secondary Outcomes: The primary outcome was the incidence of POST 24 hours postoperatively. Secondary outcomes included the incidence of POST in the post-anesthesia care unit (PACU) and at 6 hours postoperatively. Results: Of the 144 participants, 76 were in Groups S and 68 in Group N. The incidence of POST at 24 hours was significantly higher in Group S compared to Group N (57.90% vs 29.40%, Conclusion: The administration of succinylcholine (1 mg/kg) during LMA-assisted general anesthesia was associated with an increased risk of POST 24 hours postoperatively. Further longitudinal research with extended follow-up is warranted to explore the relationship between succinylcholine-induced myalgia and POST development. Trial Registration Number: ChiCTR2200056918.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.